Your browser doesn't support javascript.
loading
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.
Gollins, Simon; West, Nick; Sebag-Montefiore, David; Myint, Arthur Sun; Saunders, Mark; Susnerwala, Shabbir; Quirke, Phil; Essapen, Sharadah; Samuel, Leslie; Sizer, Bruce; Worlding, Jane; Southward, Katie; Hemmings, Gemma; Tinkler-Hundal, Emma; Taylor, Morag; Bottomley, Daniel; Chambers, Philip; Lawrie, Emma; Lopes, Andre; Beare, Sandy.
Afiliação
  • Gollins S; Department of Oncology, North Wales Cancer Treatment Centre, Bodelwyddan, Denbighshire LL18 5UJ, UK.
  • West N; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK.
  • Sebag-Montefiore D; St James' Institute of Oncology, University of Leeds, Leeds LS9 7TF, UK.
  • Myint AS; Clatterbridge Cancer Centre, Clatterbridge Road, Wirral CH63 4JY, UK.
  • Saunders M; The Christie NHS Foundation Trust, Withington, Manchester M20 4BX, UK.
  • Susnerwala S; Royal Preston Hospital, Fulwood, Preston PR2 9HT, UK.
  • Quirke P; Pathology and Tumour Biology, Level 4 Wellcome Trust Brenner Building, St James University Hospital, Beckett Street, Leeds LS9 7TF, UK.
  • Essapen S; St Luke's Cancer Centre, Egerton Road, Guildford GU2 7XX, UK.
  • Samuel L; Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK.
  • Sizer B; Colchester General Hospital, Turner Road, Colchester CO4 5JL, UK.
  • Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Clifford Bridge Road, Coventry CV2 2DX, UK.
  • Southward K; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK.
  • Hemmings G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK.
  • Tinkler-Hundal E; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK.
  • Taylor M; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK.
  • Bottomley D; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK.
  • Chambers P; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK.
  • Lawrie E; Cancer Research UK & UCL Cancer Trials Centre, University College London, 90 Tottenham Court Road, London W1T 4TJ, UK.
  • Lopes A; Cancer Research UK & UCL Cancer Trials Centre, University College London, 90 Tottenham Court Road, London W1T 4TJ, UK.
  • Beare S; Cancer Research UK & UCL Cancer Trials Centre, University College London, 90 Tottenham Court Road, London W1T 4TJ, UK.
Br J Cancer ; 117(9): 1286-1294, 2017 Oct 24.
Article em En | MEDLINE | ID: mdl-28859058
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Retais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas p21(ras) / Quimiorradioterapia / GTP Fosfo-Hidrolases / Proteínas de Membrana / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Retais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas p21(ras) / Quimiorradioterapia / GTP Fosfo-Hidrolases / Proteínas de Membrana / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido